These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2094588)

  • 1. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
    Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
    Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
    J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.
    Stürchler D; Zimmer G; Berger R; Etlinger H; Fernex M; Matile H; Just M
    Bull World Health Organ; 1990; 68 Suppl(Suppl):38-41. PubMed ID: 2094589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E
    Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
    Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
    Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
    Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
    Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against malaria: initial trial with an ant-sporozoite vaccine, (NANP)3-TT (RO 40-2361) in Africa (Bobo-Dioulasso, Burkina Faso)].
    Guiguemdé TR; Sturchler D; Ouédraogo JB; Drabo M; Etlinger H; Douchet C; Gbary AR; Haller L; Kambou S; Fernex M
    Bull Soc Pathol Exot; 1990; 83(2):217-27. PubMed ID: 2119897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes.
    Hollingdale MR; Appiah A; Leland P; do Rosario VE; Mazier D; Pied S; Herrington DA; Chulay JD; Ballou WR; Derks T
    Trans R Soc Trop Med Hyg; 1990; 84(3):325-9. PubMed ID: 2175464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
    Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
    Am J Trop Med Hyg; 1991 Nov; 45(5):539-47. PubMed ID: 1951863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.
    Rieckmann KH; Beaudoin RL; Cassells JS; Sell KW
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):261-5. PubMed ID: 120773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and secondary responses to (NANP) peptides by Plasmodium falciparum sporozoites in various strains of mice.
    Del Giudice G; Cheng Q; Mazier D; Meuwissen JH; Grau GE; Corradin G; Pessi A; Verdini AS; Lambert PH
    Scand J Immunol; 1989 May; 29(5):555-62. PubMed ID: 2471257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.
    Del Giudice G; Lambert PH; Mendis K; Pessi A; Tanner M
    Bull World Health Organ; 1990; 68 Suppl(Suppl):191-6. PubMed ID: 2094587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 5.1-[NANP]19, a recombinant Plasmodium falciparum vaccine candidate, in adults.
    Stürchler D; Just M; Berger R; Reber-Liske R; Matile H; Etlinger H; Takacs B; Rudin C; Fernex M
    Trop Geogr Med; 1992 Jan; 44(1-2):9-14. PubMed ID: 1496731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
    Fries LF; Gordon DM; Schneider I; Beier JC; Long GW; Gross M; Que JU; Cryz SJ; Sadoff JC
    Infect Immun; 1992 May; 60(5):1834-9. PubMed ID: 1563771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
    Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
    Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.